Lv31
340 积分 2023-01-09 加入
Genetic evidence supports the combined targeting of lipoprotein(a) and LDL cholesterol to reduce coronary artery disease risk
15分钟前
待确认
Author Correction: Chronic kidney disease
1个月前
已完结
26-A-10845-ACC SUSTAINED REDUCTIONS IN ANGIOTENSINOGEN AND BLOOD PRESSURE WITH AN RNA INTERFERENCE THERAPEUTIC: INTERIM RESULTS FROM A FIRST-IN-HUMAN PHASE 1 STUDY OF GW906 IN CHINA
2个月前
已关闭
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial
3个月前
已完结
Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a)
3个月前
已完结
Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study
3个月前
已完结
Unlocking new frontiers in kidney diseases: targeting endothelial dysfunction with emerging biomarkers and therapies
4个月前
已完结
Unlocking new frontiers in kidney diseases: targeting endothelial dysfunction with emerging biomarkers and therapies
4个月前
已关闭
A First-in-Human, Phase 1 Study to Assess the Pharmacodynamic Properties of Single-Dose Iptacopan (CLNP023X2101)
4个月前
已完结
Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates
5个月前
已完结
皖公网安备34019202002308
